Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.31015
+0.01015 (3.38%)
At close: May 15, 2026
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $1.65 million as of May 19, 2026. Its market cap has decreased by -97.47% in one year.
Market Cap
1.65M
Enterprise Value
56.46M
Revenue
3.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from 142.02M to 1.65M, a decrease of -98.84%. That is a compound annual growth rate of -36.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.65M | -55.30% |
| Dec 31, 2025 | 3.69M | -94.88% |
| Dec 31, 2024 | 72.05M | -1.32% |
| Dec 29, 2023 | 73.02M | 8.31% |
| Dec 30, 2022 | 67.41M | -58.91% |
| Dec 31, 2021 | 164.08M | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 2.07M |
| AXIM Biotechnologies | 2.06M |
| LakeShore Biopharma | 1.60M |
| Agentix | 1.52M |
| ZyVersa Therapeutics | 1.50M |
| inTerra Resources | 1.47M |
| International Stem Cell | 1.42M |
| Eloxx Pharmaceuticals | 1.33M |